Financial results - HEMALIFE MEDICAL S.R.L.

Financial Summary - Hemalife Medical S.r.l.
Unique identification code: 42207789
Registration number: J16/207/2020
Nace: 8622
Sales - Ron
23.927
Net Profit - Ron
10.833
Employees
1
Open Account
Company Hemalife Medical S.r.l. with Fiscal Code 42207789 recorded a turnover of 2024 of 23.927, with a net profit of 10.833 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Hemalife Medical S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 2.476 8.975 10.542 18.286 23.927
Total Income - EUR - - - - - 2.476 8.975 10.542 18.287 23.928
Total Expenses - EUR - - - - - 282 2.083 5.990 10.032 12.391
Gross Profit/Loss - EUR - - - - - 2.194 6.892 4.552 8.255 11.536
Net Profit/Loss - EUR - - - - - 2.125 6.628 4.236 8.072 10.833
Employees - - - - - 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 31.6%, from 18.286 euro in the year 2023, to 23.927 euro in 2024. The Net Profit increased by 2.806 euro, from 8.072 euro in 2023, to 10.833 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Hemalife Medical S.r.l.

Rating financiar

Financial Rating -
HEMALIFE MEDICAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Hemalife Medical S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hemalife Medical S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Hemalife Medical S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hemalife Medical S.r.l. - CUI 42207789

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 0 495 99 0 0
Current Assets - - - - - 2.192 7.070 5.789 14.072 11.906
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 0 0 230 222 0
Cash - - - - - 2.192 7.070 5.559 13.850 11.906
Shareholders Funds - - - - - 2.167 6.668 4.276 12.335 10.873
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 25 898 1.612 1.737 1.033
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.906 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 11.906 euro.
The company's Equity was valued at 10.873 euro, while total Liabilities amounted to 1.033 euro. Equity decreased by -1.394 euro, from 12.335 euro in 2023, to 10.873 in 2024.

Risk Reports Prices

Reviews - Hemalife Medical S.r.l.

Comments - Hemalife Medical S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.